Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines

• Franziska Weiner,

  Roles Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft

  Affiliations Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany, Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany

  ⨯
• Jan Torben Schille,

  Roles Methodology, Writing – review & editing

  Affiliations Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany, Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany

  ⨯
• Jens Ingo Hein,

  Roles Investigation

  Affiliation Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany

  ⨯
• Xiao-Feng Wu,

  Roles Resources

  Affiliation Leibniz Institute for Catalysis, Rostock, Germany

  ⨯
• Matthias Beller,

  Roles Resources

  Affiliation Leibniz Institute for Catalysis, Rostock, Germany

  ⨯
• Christian Junghanß,

  Roles Resources

  Affiliation Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany

  ⨯
• Hugo Murua Escobar ,

  Contributed equally to this work with: Hugo Murua Escobar, Ingo Nolte

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: hugo.murua.escobar@med.uni-rostock.de

  Affiliation Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany

  ⨯
• Ingo Nolte

  Contributed equally to this work with: Hugo Murua Escobar, Ingo Nolte

  Roles Conceptualization, Resources, Supervision, Writing – review & editing

  Affiliation Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany

  https://orcid.org/0000-0003-4577-3739

  ⨯